38 results
8-K
EX-99.1
3vmqp23ic4ypl147ar
3 May 19
Other Events
5:24pm
8-K
EX-99.1
upfpuimij15k6262mw
25 Apr 19
DURECT Appoints Two New Board Members
9:00am
8-K
EX-99.1
q3yu5upigzcxqoga
16 May 14
DURECT Announces POSIDUR™ (SABER®-Bupivacaine) Data Presentation at the International Anesthesia Research Society (IARS) Annual Meeting
12:00am
8-K
28yi0lme
16 May 14
DURECT Announces POSIDUR™ (SABER®-Bupivacaine) Data Presentation at the International Anesthesia Research Society (IARS) Annual Meeting
12:00am
8-K
EX-99.1
n2nnlb cibqlsnhf
1 Apr 14
Other Events
12:00am
8-K
y88uzkbb8xkm 6jej
1 Apr 14
Other Events
12:00am
8-K
EX-99.1
dykd03wnc
2 May 13
DURECT Corporation Announces First Quarter 2013 Financial Results and Update of Programs
12:00am
8-K
EX-99.1
6r9dmm34 jb
1 Mar 12
DURECT Corporation Announces Fourth Quarter and Year End 2011 Financial Results
12:00am
8-K
EX-99.1
5e7q bzzt
3 Nov 11
DURECT Corporation Announces Third Quarter 2011 Financial Results and Update of Programs
12:00am
8-K
EX-99.1
lqi sgvgvsftqh
4 Aug 11
DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs
12:00am
8-K
EX-99.1
4otvo lae0k9untjyea0
5 May 11
DURECT Corporation Announces First Quarter 2011 Financial Results and Update of Programs
12:00am
8-K
EX-99.1
6dva2ym3e8
11 Apr 11
DURECT Announces ELADUR® (TRANSDUR®-Bupivacaine) Phase II Study Results in Chronic Low Back Pain
12:00am
8-K
EX-99.1
1k5lde0afvypanw
29 Oct 08
Other Events
12:00am